Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10799757 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2016 | 12 Pages |
Abstract
Glycan biomarkers have a huge potential as disease markers for personalized medicine. The use of stable isotope labeled glycans as internal standards and heavy-isotope labeling methods will provide the necessary method precision and robustness acceptable for clinical use. This article is part of a Special Issue entitled “Glycans in personalized medicine” Guest Editor: Professor Gordan Lauc.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Juan Etxebarria, Niels-Christian Reichardt,